Goldman Sachs (GSCE) prices 4.50% fixed notes due June 29, 2029
Rhea-AI Filing Summary
The Goldman Sachs Group, Inc. is offering fixed rate notes due 2029 under its Medium-Term Notes, Series N program. The notes are U.S. dollar denominated, payable in $1,000 denominations, carry an interest rate of 4.50% per annum, have a trade date of June 25, 2026, an original issue date of June 29, 2026, and a stated maturity date of June 29, 2029. Interest is payable each June 29 and December 29, commencing December 29, 2026, and interest accrual uses the 30/360 (ISDA) day count convention.
The notes will be issued in book-entry form as a master global note (CUSIP 38151V5X2, ISIN US38151V5X26), will not be listed, and may be distributed initially by Goldman Sachs & Co. LLC. Offering mechanics, underwriting discounts, and original issue price treatment are described in the supplemental plan of distribution; certain fee-based advisory accounts may pay an original issue price that varies between specified percentages and 100% of principal.
Positive
- None.
Negative
- None.
Insights
Standard medium-term fixed-rate issuance with explicit settlement and distribution mechanics.
The pricing supplement describes a fixed 4.50% coupon on U.S. dollar notes maturing June 29, 2029, issued in $1,000 denominations and represented by a master global note. Distribution is led by Goldman Sachs & Co. LLC and may include market‑making resales.
Key dependencies include the final original issue price set on the trade date and underwriting concessions for fee‑based accounts; timing and scale are determined at pricing on June 25, 2026.
U.S. federal tax treatment and cross‑border distribution limits are highlighted.
Interest is taxable as ordinary income to U.S. holders and FATCA withholding applies consistent with Treasury regulations for obligations issued on or after July 1, 2014. The prospectus notes offering restrictions across the EEA, UK, Hong Kong, Singapore, Japan, and Switzerland.
Investors should note book‑entry issuance via DTC and transfer restrictions under certain jurisdictions; consult tax advisers for individual treatment.

